TY - JOUR
T1 - Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders
T2 - Definitions and current practice in Europe
AU - Urbano-Ispizua, A.
AU - Schmitz, N.
AU - de Witte, T.
AU - Frassoni, F.
AU - Rosti, G.
AU - Schrezenmeier, H.
AU - Gluckman, E.
AU - Friedrich, W.
AU - Cordonnier, C.
AU - Socie, G.
AU - Tyndall, A.
AU - Niethammer, D.
AU - Ljungman, P.
AU - Gratwohl, A.
AU - Apperley, J.
AU - Niederwieser, D.
AU - Bacigalupo, A.
PY - 2002
Y1 - 2002
N2 - The Accreditation Sub-Committee of the EBMT regularly publishes special reports on current practice of haemopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders. Major changes have occurred since the last report in 1998. Haemopoietic stem cell transplantation today includes allogeneic and autologous stem cells derived from bone marrow, peripheral blood and cord blood. With reduced intensity conditioning regimens in allogeneic transplantation, the age limit has increased, permitting the inclusion of older patients. New indications have emerged, such as autoimmune disorders and AL amyloidosis for autologous, and solid tumours for allogeneic transplants. Other indications, such as autologous transplantation for breast cancer have been challenged. An updated report with revised tables and operating definitions is presented here.
AB - The Accreditation Sub-Committee of the EBMT regularly publishes special reports on current practice of haemopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders. Major changes have occurred since the last report in 1998. Haemopoietic stem cell transplantation today includes allogeneic and autologous stem cells derived from bone marrow, peripheral blood and cord blood. With reduced intensity conditioning regimens in allogeneic transplantation, the age limit has increased, permitting the inclusion of older patients. New indications have emerged, such as autoimmune disorders and AL amyloidosis for autologous, and solid tumours for allogeneic transplants. Other indications, such as autologous transplantation for breast cancer have been challenged. An updated report with revised tables and operating definitions is presented here.
KW - Europe
KW - Haemopoietic transplantation
KW - Indications
KW - Practice
KW - Recommendations
UR - http://www.scopus.com/inward/record.url?scp=0036015532&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036015532&partnerID=8YFLogxK
U2 - 10.1038/sj.bmt.1703535
DO - 10.1038/sj.bmt.1703535
M3 - Article
C2 - 12180107
AN - SCOPUS:0036015532
SN - 0268-3369
VL - 29
SP - 639
EP - 646
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
IS - 8
ER -